GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Book Value per Share

Austar Lifesciences (Austar Lifesciences) Book Value per Share : $0.21 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Book Value per Share?

Austar Lifesciences's book value per share for the quarter that ended in Dec. 2023 was $0.21.

During the past 12 months, Austar Lifesciences's average Book Value Per Share Growth Rate was -15.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Austar Lifesciences was 55.10% per year. The lowest was -6.20% per year. And the median was 7.00% per year.

Austar Lifesciences's current price is $0.005. Its book value per share for the quarter that ended in Dec. 2023 was $0.21. Hence, today's PB Ratio of Austar Lifesciences is 0.02.

During the past 11 years, the highest P/B Ratio of Austar Lifesciences was 24.75. The lowest was 0.44. And the median was 1.57.


Austar Lifesciences Book Value per Share Historical Data

The historical data trend for Austar Lifesciences's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Book Value per Share Chart

Austar Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.16 0.24 0.25 0.21

Austar Lifesciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.25 0.25 0.23 0.21

Competitive Comparison of Austar Lifesciences's Book Value per Share

For the Medical Devices subindustry, Austar Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Austar Lifesciences's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Austar Lifesciences's PB Ratio falls into.



Austar Lifesciences Book Value per Share Calculation

Austar Lifesciences's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(108.3-0.0)/512.6
=0.21

Austar Lifesciences's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(108.3-0.0)/512.6
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Austar Lifesciences  (OTCPK:AULSF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Austar Lifesciences Book Value per Share Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Austar Lifesciences (Austar Lifesciences) Business Description

Traded in Other Exchanges
Address
No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines